Theravance Biopharma, Inc.

NasdaqGM:TBPH 株式レポート

時価総額:US$472.6m

Theravance Biopharma マネジメント

マネジメント 基準チェック /34

Theravance Biopharmaの CEO はRick Winninghamで、 Jun2014年に任命され、 の在任期間は 10.42年です。 の年間総報酬は$ 4.32Mで、 24.3%給与と75.7%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の3.91%を直接所有しており、その価値は$ 18.49M 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と6.8年です。

主要情報

Rick Winningham

最高経営責任者

US$4.3m

報酬総額

CEO給与比率24.3%
CEO在任期間10.4yrs
CEOの所有権3.9%
経営陣の平均在職期間2.4yrs
取締役会の平均在任期間6.8yrs

経営陣の近況

Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

May 02
Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

Recent updates

With Theravance Biopharma, Inc. (NASDAQ:TBPH) It Looks Like You'll Get What You Pay For

Nov 12
With Theravance Biopharma, Inc. (NASDAQ:TBPH) It Looks Like You'll Get What You Pay For

We're Interested To See How Theravance Biopharma (NASDAQ:TBPH) Uses Its Cash Hoard To Grow

Jul 16
We're Interested To See How Theravance Biopharma (NASDAQ:TBPH) Uses Its Cash Hoard To Grow

Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

May 02
Shareholders May Be More Conservative With Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation For Now

Some Confidence Is Lacking In Theravance Biopharma, Inc.'s (NASDAQ:TBPH) P/S

Feb 05
Some Confidence Is Lacking In Theravance Biopharma, Inc.'s (NASDAQ:TBPH) P/S

Upgrade: Analysts Just Made A Sizeable Increase To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Forecasts

Nov 11
Upgrade: Analysts Just Made A Sizeable Increase To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Forecasts

Theravance to purchase $95M of ordinary shares

Sep 28

Things Look Grim For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Today's Downgrade

Sep 21
Things Look Grim For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Today's Downgrade

Theravance Biopharma announces $250M capital return program

Sep 19

Theravance Biopharma GAAP EPS of -$0.11, revenue of $11.1M

Aug 04

Theravance: All-Round Failure

Mar 10

Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Just Trimmed Their Revenue Forecasts By 27%

Aug 09
Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Just Trimmed Their Revenue Forecasts By 27%

Theravance Bio stock falls 6% after nezulcitinib flunks mid-stage COVID-19 induced lung injury study

Jun 21

Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Are Reducing Their Forecasts For This Year

May 09
Theravance Biopharma, Inc. (NASDAQ:TBPH) Analysts Are Reducing Their Forecasts For This Year

CEO報酬分析

Theravance Biopharma の収益と比較して、Rick Winningham の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$49m

Jun 30 2024n/an/a

-US$46m

Mar 31 2024n/an/a

-US$45m

Dec 31 2023US$4mUS$1m

-US$55m

Sep 30 2023n/an/a

-US$61m

Jun 30 2023n/an/a

-US$68m

Mar 31 2023n/an/a

-US$75m

Dec 31 2022US$6mUS$1m

-US$93m

Sep 30 2022n/an/a

-US$136m

Jun 30 2022n/an/a

-US$196m

Mar 31 2022n/an/a

-US$226m

Dec 31 2021US$4mUS$1m

-US$265m

Sep 30 2021n/an/a

-US$266m

Jun 30 2021n/an/a

-US$264m

Mar 31 2021n/an/a

-US$275m

Dec 31 2020US$7mUS$1m

-US$295m

Sep 30 2020n/an/a

-US$285m

Jun 30 2020n/an/a

-US$270m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$6mUS$984k

-US$236m

Sep 30 2019n/an/a

-US$221m

Jun 30 2019n/an/a

-US$222m

Mar 31 2019n/an/a

-US$223m

Dec 31 2018US$3mUS$957k

-US$216m

Sep 30 2018n/an/a

-US$252m

Jun 30 2018n/an/a

-US$260m

Mar 31 2018n/an/a

-US$285m

Dec 31 2017US$2mUS$933k

-US$285m

報酬と市場: Rickの 総報酬 ($USD 4.32M ) は、 US市場 ($USD 2.18M ) の同規模の企業の平均を上回っています。

報酬と収益: Rickの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Rick Winningham (64 yo)

10.4yrs

在職期間

US$4,318,531

報酬

Mr. Rick E. Winningham, M.B.A., served as Chairman of Retrotope Inc. since February 2021 until January 2022. He serves as Director at Rivus Pharmaceuticals, Inc. since 2024. He has been Lead Independent Di...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Rick Winningham
CEO & Director10.4yrsUS$4.32m3.91%
$ 18.5m
Aziz Sawaf
Senior VP & CFO1.8yrsUS$1.39m0.65%
$ 3.1m
Stuart Knight
Senior VP of IT&I and Chief Information Officerno dataデータなしデータなし
Gail Cohen
Vice President of Corporate Communications & Investor Relationsno dataデータなしデータなし
Brett Grimaud
Senior VP2.4yrsデータなし0.70%
$ 3.3m
Rhonda Farnum
Chief Business Officer and Senior VP of Commercial & Medical Affairs2.9yrsUS$942.81k0.66%
$ 3.1m
Stacy Pryce
Senior VP & Chief Strategy Officer2.2yrsデータなしデータなし
Aine Miller
SVP of Dev.no dataデータなし0.33%
$ 1.5m

2.4yrs

平均在職期間

54.5yo

平均年齢

経験豊富な経営陣: TBPHの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Rick Winningham
CEO & Director11.3yrsUS$4.32m3.91%
$ 18.5m
Eran Broshy
Independent Director10.4yrsUS$205.14k0.14%
$ 672.9k
Deepika Pakianathan
Independent Director4.3yrsUS$207.68k0.096%
$ 455.6k
Dean Mitchell
Lead Independent Director10.4yrsUS$211.73k0.16%
$ 774.2k
James Kelly
Independent Director1.6yrsUS$43.10kデータなし
Donal O'Connor
Independent Director9.1yrsUS$195.80k0.13%
$ 610.7k
Susannah Gray
Independent Chairman1.8yrsUS$346.47k0.064%
$ 302.6k
Laurie Smaldone Alsup
Independent Director6.8yrsUS$197.68k0.13%
$ 618.2k
Jeremy Grant
Independent Directorless than a yearUS$168.36k0.045%
$ 214.4k

6.8yrs

平均在職期間

64.5yo

平均年齢

経験豊富なボード: TBPHの 取締役会経験豊富 であると考えられます ( 6.8年の平均在任期間)。